ABSCI CORP.
-
USD
(-)
- 15 min delayed data - NASDAQ Stocks
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | ABSI |
| ISIN: |
ABSCI CORP. news, videos and press releases - Page 2
For more news please use our advanced search feature.
ABSCI CORP. - More news...
ABSCI CORP. - More news...
- 03/01/2024 - 21:01 Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- 02/28/2024 - 03:20 Absci Announces Pricing of Public Offering of Common Stock
- 02/27/2024 - 21:01 Absci Announces Proposed Public Offering of Common Stock
- 02/21/2024 - 12:30 Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
- 02/20/2024 - 13:00 Absci to Participate in Upcoming Investor Conferences
- 01/10/2024 - 12:30 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
- 01/08/2024 - 12:00 Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
- 01/03/2024 - 13:00 Absci to Participate in the 26th Annual Needham Growth Conference
- 12/28/2023 - 13:00 Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- 12/20/2023 - 12:30 Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
- 12/04/2023 - 12:30 Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
- 11/15/2023 - 13:00 Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
- 11/14/2023 - 21:05 Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
- 11/14/2023 - 07:05 Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
- 10/26/2023 - 12:00 Absci to Participate in Upcoming Investor Conferences
- 09/21/2023 - 12:00 Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
- 09/06/2023 - 12:00 Absci to Host R&D Day on October 4, 2023
- 08/28/2023 - 20:05 Absci to Participate in Upcoming Investor Conferences
- 08/14/2023 - 12:02 Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
- 08/14/2023 - 12:00 Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
- 08/10/2023 - 12:00 Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
- 07/26/2023 - 12:00 Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
- 06/15/2023 - 12:00 Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
- 06/06/2023 - 12:00 Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
- 05/15/2023 - 20:05 Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
- 05/11/2023 - 12:00 University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
- 04/06/2023 - 12:00 Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
- 04/04/2023 - 12:00 Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
- 03/30/2023 - 20:05 Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
- 03/23/2023 - 12:00 Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
